Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Cancer drug shows promise in battling Parkinson’s disease

Cancer drug shows promise in battling Parkinson’s disease

Leukemia patients treated with common cancer drug have heightened risk of heart failure

Leukemia patients treated with common cancer drug have heightened risk of heart failure

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Novel and targeted cellular product causes cell death in non-Hodgkin lymphoma models

Novel and targeted cellular product causes cell death in non-Hodgkin lymphoma models

New strategy could prevent side effects of targeted cancer treatment

New strategy could prevent side effects of targeted cancer treatment

NCCN Patient Advocacy Summit closes gaps in perspective of value in cancer care

NCCN Patient Advocacy Summit closes gaps in perspective of value in cancer care

New therapy shows dramatic effect against worst types of leukaemias

New therapy shows dramatic effect against worst types of leukaemias

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

Study provides most detailed classification of acute myeloid leukemia, myelodysplastic syndrome

Study provides most detailed classification of acute myeloid leukemia, myelodysplastic syndrome

Researchers aim to exploit DNA mutations in the treatment of blood and bone marrow cancers

Researchers aim to exploit DNA mutations in the treatment of blood and bone marrow cancers

Transplant patient finds out his DNA has been replaced by that of his donor

Transplant patient finds out his DNA has been replaced by that of his donor

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Scientists highlight the benefits of Droplet Digital PCR technology at the 2019 ASH meeting

Scientists highlight the benefits of Droplet Digital PCR technology at the 2019 ASH meeting

Combination therapy is safe and effective for older patients diagnosed with acute lymphoblastic leukemia

Combination therapy is safe and effective for older patients diagnosed with acute lymphoblastic leukemia

Rutgers researchers identify small mutations for AML and MDS through deep DNA sequencing

Rutgers researchers identify small mutations for AML and MDS through deep DNA sequencing

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

Pairing chemotherapy azacitidine with enasidenib boosts complete remission in AML patients

Pairing chemotherapy azacitidine with enasidenib boosts complete remission in AML patients

Yale study highlights the need to develop effective, less toxic approaches to treat AML patients

Yale study highlights the need to develop effective, less toxic approaches to treat AML patients

Thermo Fisher Scientific to accelerate genomic profiling process in hematology and oncology labs

Thermo Fisher Scientific to accelerate genomic profiling process in hematology and oncology labs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.